HDAC9 exacerbates endothelial injury in cerebral ischaemia/reperfusion injury

Journal of Cellular and Molecular Medicine

Volumn 20, Issue 6, 2016, Pages 1139-1149

  Shi, Weichen ^a,b   Wei, Xinbing ^a   Wang, Ziying ^a   Han, Huirong ^a   Fu, Yi ^a   Liu, Jiang ^a   Zhang, Yan ^a   Guo, Jian ^a   Dong, Chuanqiao ^a   Zhou, Di ^a   Zhou, Quan ^a   Chen, Yuxin ^b   Yi, Fan ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Autophagy; Blood brain barrier; Gene therapy; Histone deacetylase; Ischaemic stroke

Indexed keywords

HISTONE DEACETYLASE 9; PROTEIN P62; PROTEIN ZO1; TIGHT JUNCTION PROTEIN; GLUCOSE; HDAC9 PROTEIN, RAT; HISTONE DEACETYLASE; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; BRAIN ISCHEMIA; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM INJURY; GENE OVEREXPRESSION; GENE SILENCING; HEMISPHERE; IMMUNOFLUORESCENCE TEST; INFLAMMATION; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA INTERFERENCE; STEREOTACTIC PROCEDURE; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; WESTERN BLOTTING; ANIMAL; BRAIN; COMPLICATION; DEFICIENCY; ENDOTHELIUM CELL; ENZYMOLOGY; GENE TRANSFER; GENETICS; LENTIVIRINAE; METABOLISM; MICROVASCULATURE; PATHOLOGY; REPERFUSION INJURY; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE; VASCULARIZATION;

ANIMALS; APOPTOSIS; AUTOPHAGY; BLOOD-BRAIN BARRIER; BRAIN; BRAIN ISCHEMIA; CELL MEMBRANE PERMEABILITY; ENDOTHELIAL CELLS; GENE SILENCING; GENE TRANSFER TECHNIQUES; GLUCOSE; HISTONE DEACETYLASES; INFLAMMATION; LENTIVIRUS; MALE; MICROVESSELS; OXYGEN; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; UP-REGULATION;

EID: 84958609363     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12803     Document Type: Article

References (41)

1. Sierra C, Coca A, Schiffrin EL. Vascular mechanisms in the pathogenesis of stroke. Curr Hypertens Rep. 2011; 13: 200-7.
2. Schweizer S, Meisel A, Marschenz S. Epigenetic mechanisms in cerebral ischemia. J Cereb Blood Flow Metab. 2013; 33: 1335-46.
3. Shakespear MR, Halili MA, Irvine KM, et al. Histone deacetylases as regulators of inflammation and immunity. Trends Immunol. 2011; 32: 335-43.
4. Shein NA, Shohami E. Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries. Mol Med. 2011; 17: 448-56.
5. Venkataramani V, Rossner C, Iffland L, et al. Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein. J Biol Chem. 2010; 285: 10678-89.
6. Kim D, Frank CL, Dobbin MM, et al. Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity. Neuron. 2008; 60: 803-17.
7. Rivieccio MA, Brochier C, Willis DE, et al. HDAC6 is a target for protection and regeneration following injury in the nervous system. Proc Natl Acad Sci USA. 2009; 106: 19599-604.
8. Langley B, Brochier C, Rivieccio MA. Targeting histone deacetylases as a multifaceted approach to treat the diverse outcomes of stroke. Stroke. 2009; 40: 2899-905.
9. He M, Zhang B, Wei X, et al. HDAC4/5-HMGB1 signalling mediated by NADPH oxidase activity contributes to cerebral ischaemia/reperfusion injury. J Cell Mol Med. 2013; 17: 531-42.
10. International Stroke Genetics Consortium, Wellcome Trust Case Control Consortium, Bellenguez C, et al. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet. 2012; 44: 328-33.
11. Markus HS, Makela KM, Bevan S, et al. Evidence HDAC9 genetic variant associated with ischemic stroke increases risk via promoting carotid atherosclerosis. Stroke. 2013; 44: 1220-5.
12. Wang Z, Wei X, Zhang Y, et al. NADPH oxidase-derived ROS contributes to upregulation of TRPC6 expression in puromycin aminonucleoside-induced podocyte injury. Cell Physiol Biochem. 2009; 24: 619-26.
13. Cetin A, Komai S, Eliava M, et al. Stereotaxic gene delivery in the rodent brain. Nat Protoc. 2006; 1: 3166-73.
14. Zhou L, Li F, Xu HB, et al. Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95. Nat Med. 2010; 16: 1439-43.
15. Wang Z, Wei X, Liu K, et al. NOX2 deficiency ameliorates cerebral injury through reduction of complexin II-mediated glutamate excitotoxicity in experimental stroke. Free Radic Biol Med. 2013; 65C: 942-51.
16. Mocco J, Mack WJ, Ducruet AF, et al. Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circ Res. 2006; 99: 209-17.
17. Wang Z, Leng Y, Tsai LK, et al. Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J Cereb Blood Flow Metab. 2011; 31: 52-7.
18. Zhou M, Tang W, Fu Y, et al. Progranulin protects against renal ischemia/reperfusion injury in mice. Kidney Int. 2015; 87: 918-29.
19. Zhang Y, Wei X, Liu L, et al. TIPE2, a novel regulator of immunity, protects against experimental stroke. J Biol Chem. 2012; 287: 32546-55.
20. Osada T, Gu YH, Kanazawa M, et al. Interendothelial claudin-5 expression depends on cerebral endothelial cell-matrix adhesion by beta(1)-integrins. J Cereb Blood Flow Metab. 2011; 31: 1972-85.
21. Yi F, Zhang AY, Janscha JL, et al. Homocysteine activates NADH/NADPH oxidase through ceramide-stimulated Rac GTPase activity in rat mesangial cells. Kidney Int. 2004; 66: 1977-87.
22. Rajendran P, Rengarajan T, Thangavel J, et al. The vascular endothelium and human diseases. Int J Biol Sci. 2013; 9: 1057-69.
23. Hainsworth AH, Oommen AT, Bridges LR. Endothelial cells and human cerebral small vessel disease. Brain Pathol. 2015; 25: 44-50.
24. Balduini W, Carloni S, Buonocore G. Autophagy in hypoxia-ischemia induced brain injury: evidence and speculations. Autophagy. 2009; 5: 221-3.
25. Wang P, Xu TY, Wei K, et al. ARRB1/beta-arrestin-1 mediates neuroprotection through coordination of BECN1-dependent autophagy in cerebral ischemia. Autophagy. 2014; 10: 1535-48.
26. Zhang X, Yan H, Yuan Y, et al. Cerebral ischemia-reperfusion-induced autophagy protects against neuronal injury by mitochondrial clearance. Autophagy. 2013; 9: 1321-33.
27. Uchiyama Y, Koike M, Shibata M. Autophagic neuron death in neonatal brain ischemia/hypoxia. Autophagy. 2008; 4: 404-8.
28. Qin AP, Liu CF, Qin YY, et al. Autophagy was activated in injured astrocytes and mildly decreased cell survival following glucose and oxygen deprivation and focal cerebral ischemia. Autophagy. 2010; 6: 738-53.
29. Grishchuk Y, Ginet V, Truttmann AC, et al. Beclin 1-independent autophagy contributes to apoptosis in cortical neurons. Autophagy. 2011; 7: 1115-31.
30. Nussenzweig SC, Verma S, Finkel T. The role of autophagy in vascular biology. Circ Res. 2015; 116: 480-8.
31. Urbanek T, Kuczmik W, Basta-Kaim A, et al. Rapamycin induces of protective autophagy in vascular endothelial cells exposed to oxygen-glucose deprivation. Brain Res. 2014; 1553: 1-11.
32. Bachetti T, Ceccherini I. Tumor necrosis factor receptor-associated periodic syndrome as a model linking autophagy and inflammation in protein aggregation diseases. J Mol Med (Berl). 2014; 92: 583-94.
33. Nighot PK, Hu CA, Ma TY. Autophagy enhances intestinal epithelial tight junction barrier function by targeting claudin-2 protein degradation. J Biol Chem. 2015; 290: 7234-46.
34. Yi C, Ma M, Ran L, et al. Function and molecular mechanism of acetylation in autophagy regulation. Science. 2012; 336: 474-7.
35. Donohoe DR, Garge N, Zhang X, et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 2011; 13: 517-26.
36. Wang X, Liu J, Zhen J, et al. Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy. Kidney Int. 2014; 86: 712-25.
37. Dailey T, Tajiri N, Kaneko Y, et al. Regeneration of neuronal cells following cerebral injury. Front Neurol Neurosci. 2013; 32: 54-61.
38. Posada-Duque RA, Barreto GE, Cardona-Gomez GP. Protection after stroke: cellular effectors of neurovascular unit integrity. Front Cell Neurosci. 2014; 8: 231.
39. Parra M. Class IIa HDACs - new insights into their functions in physiology and pathology. FEBS J. 2015; 282: 1736-44.
40. Sugo N, Oshiro H, Takemura M, et al. Nucleocytoplasmic translocation of HDAC9 regulates gene expression and dendritic growth in developing cortical neurons. Eur J Neurosci. 2010; 31: 1521-32.
41. Lang B, Alrahbeni TM, Clair DS, et al. HDAC9 is implicated in schizophrenia and expressed specifically in post-mitotic neurons but not in adult neural stem cells. Am J Stem Cells. 2012; 1: 31-41.